<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 291 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page290.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=291">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 291 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 291</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=291"><img src="../thumb/291.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>254 / 2020-04                                                            Anti-Microbials - 18.10
   triglyceridaem., hypercholesterolaem., hypokalaem., polyruia, thirst,   Drug interactions: Incr.plasma conc.of meds. metabol. by cyto-  (S4) LYOPHIL.POWD.FOR SOL.FOR INFUS, 45/20.2.2/0023, 0024
   intermenst.bleed., leukorrh., menorrhag., fem.sex.dysfunct., flush.,   chrome P-450 system, anticoag. effs.incr.with warfar., sulphonylur.  723734-001: 50 mg/10 ml, sngl.vial, R1 983,54
   malaise, rigors, fatig., abnorm.vis., taste pervers.  hypoglycaem. plasma conc.poss.incr., decr.phenytoin metab.with   723733-001: 70 mg/10 ml, sngl.vial, R1 983,54
   Special precautions: Monit.pts.receiv.concom. terfenadine at flu-  poss. toxic., decr.theophyll.clear.lead.to poss. toxic., incr.zidovudine   Dosage: Slow IV infus.over 1 hr. Do not use any diluent.contain.dextr.
   conazole dos.&gt;400 mg/day, AIDS pts. more suscept.to cutan.reacts.,   plasma conc., ser.life-threat. card. dysrhythm.incl.torsades de pointes   or mix/co-infuse with other meds.
             +
   IV infus.in pts. requir. Na /fluid restsrict., imp.ren.funct., bleed. events   with cisapride, signif.ciclospor.ser.conc.incr., incr. midazolam & tria-  Adults:
   report.with concom.warfar., incr.risk of theophyll. toxic., uveit.in pts.  zolam/rifabutin/tacrolimus ser. conc., hydrochlorothiaz.incr.flucona-  Empiric.ther: Load.dos: 70 mg as sngl.dos. on day 1, follow.by 50 mg
   receiv.rifabutin, nephrotox. report.with tracrolimus, discont.ther. when   zole plasma conc., rifampicin decr.fluconazole plasma conc., nevirap-  dly.thereaft. Durat.bas. on clinic. respons.cont.until neutropen.resolv.
   pts.with syst.fung.infects.develop.bullous les./ erythema multiforme,   ine expos.incr.by approx.100%.  Treat pts. found to have fung.infect.min.x14 days contin. x7 days aft.
   concom.meds.metabol. by cytochrome P-450 system            neutropen.& sympts.resolv. If well tol. dly. dos.may be incr.to 70 mg
   Warnings: Monit.pts.develop.abnorm.liv.funct.for more serious   LAMISIL, Novartis [P/S]  if adeq.respons.not obt.
   hepat.injur.                 Terbinafine HCl               Invasive candidiasis: Load.dos.70 mg on day 1 foll.by 50 mg dly.
   Drug interactions: Prolongs prothromb.time in warfarin ther., pro-  Indications: Fung.skin infect.caus.by dermatophyt., ringworm &   thereaft. Durat.dictat.by clinic.& microbiolog.respon. Contin.for at
   longs serum half-life of oral sulphonylureas, incr.midazolam conc.  yeast skin infect., onychomycos., tinea capitis in childr.  least.14 days aft. last.posit.cult., pts.remain.persist.neutropen.may
                                (S4) TABS, Z/20.2.2/185
   partic.aft. oral admin., cyclospor.conc.grad.incr.aft.ren. transplantat.,   warrant longer ther.pend.resolut.
   multiple hydrochlorothiazide dos. incr. fluconazole plasma conc., phe-  792713-001: 250 mg, 14, R902,87  Oesophageal & oropharyngeal candidiasis: 50 mg dly.
                                Dosage: Childr: No data avail.for childr.und.2 yrs (&lt;12 kg): Tinea
   nytoin/ rifabutin/ tacrolimus plasma conc.incr., theophyll. clear. reduc.,   Invasive Aspergillosis: 70 mg sngl load.dos. on day 1 foll.by 50 mg
   rifampicin reduc.fluconazole plasma conc., incr.zidovudine plasma   capitis: Admin.once dly.x4wks. &gt;40 kg: 250 mg.  dly.thereaft. Durat.based on sev.of pts.underly.dis/recov.from immu-
   conc., incr. terfenadine conc.follow.high dos.fluconazole assoc. with   Adults: 250 mg 1xdly.until infect.clear. Tinea pedis: 2-6 wks., T cor-  no-suppress. & clinic respons. Dly.dos.incr.to 70 mg may be consid.
   ECG abnormalit., card.arrhythm.with cisapride, incr.plasma conc.of   poris/ cruris: 2-4 wks, Cutan.candidias: 2-4 wks. In onychomycos.  if no evid.of clinic.respons.& ther. well tol.
   meds.metabol.by cytochrome P-450 system  treat for 6 wks.-3 mnths.  Paeds: Dos. in childr.& adolesc.(3 mnths. - 17 yrs of age) based on
                                Contraindications: Safety in pregn.not est., lactat., imp.liv.funct.
                                                              body surf. area (ref.to prod.lit.for calc.)
   FUNGIZONE, Equity [P/S]      Side effects: GI disords., skin reacts.incl.Stev. Johns.syndr./tox.  All indicats: Sngl.70 mg/m 2  load.dos.(not exceed. act. dos. of 70
   Amphotericin-B.              epiderm.necrolys.& ac.generalis. exanthematos.pustolos., psorias.  mg) admin on day 1 follow.by 50 mg/m  dly.thereaft.(not exceed.
                                                                               2
   Indications: Potent.life-threat.fung.infect. eg.cryptococcos./N.  form erupts./-exacerbat., anaphylact.reacts., taste disturbs., weight   act. dos. of 70 mg dly). Indiv.treatm.durat.to each indicat.as describ.
   Americ.blastomycos./ dissem. monilias./coccidioidomycos./histo-  loss, headache, hepatobil.dysfunct.incl.liv. fail., bld.dyscras., hair   for each indicat.in adults. If 50 mg/m well tol. dly.dos.may be incr.
                                                                              2
   plasmos./ mucormycos. (phycomycos.)/sporotrichos. & aspergil-  loss, fatig., cutan./system SLE, dizzin., par-/hypoaesthes., muscu-  to 70 mg/m  (not exceed. act. dos.of 70 mg) if adeq.respons.not obt.
                                                                   2
   los. Poss.helpful in Americ. mucocutan. leishmanias. but not med.  loskelet. reacts.  Contraindications: Sev.hepat.insuff., paeds.with any degree of
   of choice in prim.ther.      Warnings and special precautions: Chron./ act.liv.dis/imp.ren.   hepat.insuffic., safety & effic.in childr. &lt; 3 mnths.not est., paeds.with
   (S4) IV INFUS, A/20.1.7/150  funct., discont.in cases of hepatobil.dysfunct., progress.skin rash/bld.   endocardit./ osteomyelit./meningit.due to Candida, init.ther.for invas.
   727555-006: 50 mg, 1, R46,96  dyscras., limit.exper.in treatm.&gt;6 mnths., lact.intol.  aspergillos.in paeds., pregn.& lactat.
   For further details ref.to professional info.  Drug interactions: Clear.accelerat.by meds. which induc.me-  Side effects: Anaem., headache, loc.reacts., GI disords., skin reacts.
   GLENMARK-FLUCONAZOLE, (Activo)   tabol., cimetid.decr.clear., rifampic. incr.clear., menstr.irregul.with   incl.Stev.-Johns.syndr./tox. epiderm. necrolys., sweat., erythema,
                                OC’s, inhib./enhanc. clear.of meds.metabol.by cytochrom.P-450
   Glenmark [P/S]               syst., inhibit. CYP2D6 mediat.metabol., ciclospor.clear. incr.,   dyspn., tachycard., flush., fev., pain, chills, poss. histamine-mediat.
   Fluconazole                  desipramine clear.decr.       sympts.incl.facial swell./ warmth. sensat.& brochosp., anaphylax.,
   Indications: Adults: Cryptococ.meningit.in ment. alert pts.without   hepat. dysfunct., hypersens., swell.& periph.oed., elev. liv. enzyme
   loc.neurologic.signs & follow-up ther.aft. amphotericin B ther., maint.  LAMISPOR, Cipla Medpro [P/S]  levs., hypercalcaem., phlebit./ thrombophlebit., drug-relat.lab.ab-
   ther.to prev. cryptococ. dis.relapse in AIDS pts., system. candidias.,   Terbinafine HCl.  normalities. Paed.also: hypotens.
   oropharyng.& oesophag.candidias., fung. infect.prophylax.in pts.re-  Indications: Fung.skin infect.caus.by Trichophyton, Microsporum   Warnings and special precautions:. Std. monit. of tacrolimus
   ceiv.chemo and/or radiother., vag.candidias.ac./recurr.infects.& as   canis & Epidermophyton floccosum, ringworm where oral ther. ap-  bld.conc.& approp.dos. adjustm. recomm.for pts rec.both ther, long.
   prophylax. reduc.recurr.infect.incid., candidial. balanit., dermatomy-  propr. due to site/sev.of infect., onychomycos.  course of ther.pend.resolut.of neutropen.in pts remain persistent. neu-
                                                                                       2
   cos.incl.onychomycos.& derm. candida infects.  (S4) TABS, A40/20.2.2/0614  tropenic, consid.dly.dos.of 70mg cancidas (Paeds: 70 mg/m  dly not
   (S4) TABS, 42/20.2.2/0369, 0370, 0371  711778-001: 250 mg, 14, R345,80  exceed.act. dly.dos. of 70 mg) with concom.metabol.induc. efavirenz/
   720857-001: 50 mg, 14, R131,28  Dosage: Adults: Usual recomm.dos: 250 mg once dly.  nevirapine/rifampcin/dexamethas./ phenytoin/carbamazepine, mod.
                                                              hepat.insuff., discont.in case of anaphylax., monit.liv.enzym. closely
   720858-001: 150 mg, 1, R24,29  Treatm.durat.varies accord.to indicat.& sev. Tinea pedis: 2-6 wks.
   720859-001: 200 mg, 30, R518,28  Tinea corporis: 4 wks., Tinea cruris: 2-4 wks. Onychomycos: 6   with concom.cyclosporin, monit.pts. develop. abnorm.LFTs for evid.of
   Dosage: Adults:              wks.-3 mnths.                 worsen.hepat. funct. & eval.risk-benef.of contin.ther.
   Cryptococ.meningit: Init. 400 mg on 1st day, then 200-400 mg dly   Contraindications: Imp.liv.funct., safety in pregn. & lactat.not   Drug interactions: 12 hr.bld.conc.of tacrolimus reduc., elev.liv.test
   depend.on clinic.respons. Durat. usual.8 wks follow.amphotericin   est., not recomm.in childr.due to limit.data on use, use in chron./  val. & incr.AUC with cyclosporine, conc.reduc.by drug clear.induc.
   B ther.& 10 wks. for monother. Maint. to prevent.relapse in AIDS   act.liv.dis.not recomm.  eg. efavirenz/nevirapine/phenytoin/dexamethasone or carbamazep.
   pts: 100-200 mg/day.         Side effects: Bld.dyscras., psych.disturbs., paraesthes., hypoaes-  MYCAMINE, Astellas &
   System.candidias: 1st day 400 mg, then 200 mg dly. Dos.may be   thes., dizzin., vertigo, malaise, fatig., GI disturbs., taste loss/disturbs.,   Micafungin
   incr.to 400 mg dly.depend.on clinic./ mycolog.respons.which also   hepato-bil.syst.disords., skin & subcut.tiss. disords. incl. Stev.-Johns.  Indications: Adults, adolesc.≥16 yrs.& elderly: Invas.candid-
   determin. durat.             syndr.& tox.epiderm. necrolys., photosens., angioneurot.oed., pso-  ias., oesophag.candidias.in pts.where IV ther.appropr., candida in-
   Oropharyng.candidias: 50-100 mg dly.x7-14 days/ long.in sev.im-  rias., arthralg., myalg.  fect.prophylax.in allogen. haematopoiet.stem cell transplant./pts.
   munocompromis.pts. To prev. relapse in AIDS pts: 150 mg once wkly.  Special precautions: Excret.in breast milk, imp. ren.funct., discont.  expect. to have neutropen.(absolut.neutrophil count &lt;500 cells/
   Oesophag.candidias: 200 mg on 1  day follow. by 100-200 mg   in pres.of progress.skin rash and S&S indicat.of hepat.dysfunct., pso-  µl) for ≥ 10 days.
                   st
   dly. Dos.up to 400 mg once dly may be used if no clinic. respons.  rias. poss. exacerbat.  Childr.(incl.neonat.) & adolesc.&lt; 16 yrs.: Invas. candidias., Can-
   aft.14 days on low. dos. Treatm.durat: at least 3 wks.& x2 wks.  Drug interactions: Clear.accelerat.by meds. which induc.metabol.,   dida infect.prophylax.in allogen. haematopoiet.stem cell transplant./
   aft. sympt. resolv.          clear.inhib.by meds.which inhib. cytochrom.P-450, inhibits CYP2 D6-  pts.expected to have neutropen. (absolut. neutrophil count &lt;500
   Fung.infect.prophylax.in cytotox.chemother. &/ radiat.ther:   mediat. metabol., menstr.disturbs.with OC’s.  cells/µl) for ≥ 10 days.
   50-400 mg dly.depend.on risk profile. Init.treatm.sev.days bef.neu-  MICROCIDAL, (Aspen Pharmacare: Pharma) Pharmacare [P/S]  (S4) SOL.FOR INFUS, 44/20.2.2/0639, 0640
   tropen.expect. & contin.x7 days aft.neutrophil count rises above   Griseofulvin.  721410-001: 50 mg, single vial, R1 033,80
   1 000 cells/mm   3           Indications: Mycot.dis.of skin, hair & nails.  721409-001: 100 mg, single vial, R2 067,60
   Vag.candidias: 150 mg as sngl.dos.  (S4) TABS. K/20.1.7/218, 219.  Dosage: Slow IV infus.over 1 hr., do not mix/co-infus. with other medicin.
   Recurr.vag.candidias: 150 mg as sngl. dos. once /mnth. Ther.dur.  729566-005: 125 mg, 100, R170,26  products except those mention.in instructs.for reconstit.& dilut.(ref.to
   indiv. rang.from 4-12 mnths.  729574-008: 500 mg, 30, R230,25  prod. lit.), treatm.to be init.by medic.practit. exper. in manag.fung.infect.
   Candida balanit: 150 mg as sngl.dos.  729574-016: 500 mg, 100, R767,50  Invas.candidias: Adults, adolesc ≥16 yrs.& elderly: Body weight
   Derm.infects.& derm.candida infects: 150 mg once/wk as sngl.  Dosage: Admin.dly dose in 4 div.dos.with /aft. fatty meals. Cont.  &gt;40 kg: 100 mg/ day. Body weight &lt;40 kg: 2 mg/kg/day. If respon in-
   dos. Treatm.durat. usual. 2-4 wks.except.tinea pedis poss.requir.up to   ther.until infect.tiss.replac.ie.skin & hair: 2-6 mnths/fingernails 6-9   adeq. dos. may be incr.to 200 mg/day in pts.weigh. &gt;40 kg or 4 mg/
   6 wks. ther. In onychomycos.ther.to cont.unt. infect. nail grows out &   mnths & toenails 1 yr.  kg/day in pts. &lt;40 kg. Childr. ≥4 mnths up to adolesc &lt; 16 yrs: Body
   replac.with uninfect.nail.   Adults: 500 mg-1 g dly. Sev.infects: 1,5-2 g dly.for short period.   weight &gt;40 kg: 100 mg/ day. Body weight &lt;40 kg: 2 mg/kg/day. If re-
   Contraindications: Concom.cisapride, avoid concom. astemizole,   Childr: 10 mg/kg bm dly.  spon. inadeq.dos.may be incr.to 200 mg/day in pts.weigh. &gt;40 kg or 4
   pregn.(congenit.malformat. report), lactat., multidos.ther.in ren.im-  Contraindications: Porphyr., liv.fail., pregn.,   mg/kg/day in pts. &lt;40 kg. Childr. (incl. neonates) &lt; 4 mnths: 4 -10
   pairm., hypersens. to other azole antifung., safety & effic. in childr.  Side effects: GI disturbs., bld.disords., skin rash, dry mouth, alt.  mg/kg/ day. If CNS infect.suspect.a high.dos.(e.g.10 mg/ kg) should
   not est.for recur.vag.candidias./candida balanit. derm.infect.incl.tinea   taste, angioed., proteinur., candidias., paraesthes., photosens.,   be used. Safety & effic.in childr.incl. neonates) &lt; 4 mnths of dos.of 4
   pedis/corpor. /cruris/ onychomycos./derm.candida infects.  headache, depress., confus., dizzin., insomn., fatig., hepatotoxic.,   & 10 mg/kg for treatm. of invas.candidias.with CNS involvem.not est.
   Side effects: Ser.hepatotoxic.incl.fatalit.esp.in pts. with ser.underly.  periph.neurit.,   Treatm.duration: Minim.14 days. Cont.treatm. for at least 1 wk.aft.2
   med.condits., angioed., skin reacts. incl.Stev.Johns.syndr./tox.epi-  Special precautions: Cross.placenta, embryo toxic & teratogen.  sequent.negat.bld.cultures & aft.resolut.of clinic.signs and sympts.
   derm. necrolys., bld.dyscras., CNS effs., headache, dizzin., seiz., hy-  in rats, male pts.not to father childr.within 6 mnths of treatm., SLE   Oesophag.candidias: Adults, adolesc.≥16 yrs. & elderly:
   pokalaem., GI disturbs., hypercholesterolaem., hypertriglyceridaem.,   poss. precipitat. /aggrav., addit./alt.contracept.to OC’sx1 mnth.aft.  Body weight &gt;40 kg: 150 mg/day. Body weight &lt;40 kg: 3 mg/kg/day.
   taste pervers., hepatotox., hepat.fail., hepatit., hepatocellul. necros.,   stopp.ther., poss.penicill./penicillamine intol., lact.intol.  Cont.treatm.for at least 1 wk.aft.resolut.of clinic. signs and sympts.
   jaund., alopec., anaphylax., hyperton., abnorm.vis., vertigo, insomn.,   Drug interactions: Effs.of alcoh.enhanc., phenobarbit.decr.  Prophylax.of candida infect: Adults, adolesc. ≥16 yrs. & el-
   nervousn., fatig., rigors, malaise, hyperkines., fem. sex.dysfunct., in-  GI absorpt., dimin.eff.of oral anti-coag.& OC’s, reduc.salicylate   derly: Body weight &gt;40 kg: 50 mg/ day. Body weight &lt;40 kg: 1 mg/
   termenstr. bleed., menorrhag., leukorrh., polyur., flush., hepat./ren./  plasma conc.  kg/day. Childr.≥4 mnths. up to adolesc &lt; 16 yrs: Body weight
   haemotolog. funct.disturbs.                                &gt;40 kg: 50 mg/day. Body weight &lt;40 kg: 1 mg/ kg/day. Childr. (incl.
   Warnings and special precautions: Pass.into breast milk, monit.  MSD-CASPOFUNGIN, MSD [P/S]  neonates)&lt; 4 mnths: 2 mg/ kg/ day. Treatm.duration: Cont.treatm.
   pts.develop.abnorm.liv.funct.for more ser. hepat.injur., discont.ther.  Caspofungin anhydrous equiv.to caspofungin acetate  for at least 1 wk. aft. neutrophil recov.
   when S&S of liv.dis. devel., discont.ther.if pts.with syst./invas.   Indications: Adults: Empiric.ther.for presum. fung.infects. in fe-  Contraindications: Hypersens.to other echinocandins, pregn.& lactat.
   fung. infects.devel.bullous les./erythema multiforme, concom.war-  brile neutropen.pts., invas. Candidias. incl.candidaem., oesophag/  Side effects: Common: Leucopen., neutropen., anaem., hypoka-
   far./sulfonylurea hypoglycaem./ phenytoin/theophyll./zidovudine/   oropharyng. candidias. where IV ther.approp., invas. aspergillosis in   laem., hypomagnesaem., hypocalcaem., headache, phlebit., N&V,
   ciclospor./ midazolam & triazolam/rifabutin/ tacrolimus, monit.pts.  pts refract.to/intol.of other ther. incl amphotericin B, lipid formulat.  diarrh., abdom. pain, incr.bld.alkaline phosphat./aspart. aminotrans-
   with concom.nevirapine, monit. liv. funct.in contin.ther.long.than   of amphotericin B & itraconazole. Paed: Safety & effectiven.in pts.   fer./ alanine aminotransfer./bilirub., abnorm. LFT, rash, pyrex.,
   1 mnth./ when S&S of liv.dysfunct.devel., underly.dis.e.g. AIDS/ma-  3 mnths-17 yrs.support.by adult well-control.study evid./pharmacoki-  rigors. Uncommon: Pancytopen., thrombocytopen., eosinophil.,
   lign., elderly, imp.ren.funct.  net.data & addit.data from prospect.stud.  hypoalbuminaem., anaphylact.react., hypersens., hyperhidros., hy-</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page290.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page286.html">286</a>&nbsp;&nbsp;&nbsp;<a href="page287.html">287</a>&nbsp;&nbsp;&nbsp;<a href="page288.html">288</a>&nbsp;&nbsp;&nbsp;<a href="page289.html">289</a>&nbsp;&nbsp;&nbsp;<a href="page290.html">290</a>&nbsp;&nbsp;&nbsp;<a href="page291.html">291</a>&nbsp;&nbsp;&nbsp;<a href="page292.html">292</a>&nbsp;&nbsp;&nbsp;<a href="page293.html">293</a>&nbsp;&nbsp;&nbsp;<a href="page294.html">294</a>&nbsp;&nbsp;&nbsp;<a href="page295.html">295</a>&nbsp;&nbsp;&nbsp;<a href="page296.html">296</a>
             </td>
             <td width="35%"><a href="page292.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page292.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
